Correction Volume 17, Issue 5 pp 1368
Correction for: EpiAge: a next-generation sequencing-based ELOVL2 epigenetic clock for biological age assessment in saliva and blood across health and disease
- 1 EpiMedTech Global, Singapore 409051, Singapore
- 2 HKG Epitherapeutics Ltd., Hong Kong SAR, China
- 3 Gerald Bronfman Department of Oncology, McGill University, Montreal H4A 3T2, Canada
- 4 Department of Pharmacology & Therapeutics, McGill University, Montreal H3G 1Y6, Canada
- 5 Visiting Professor, Department of Pharmacology, Oxford University, Oxford OX13QT, UK
- 6 Department of Drug and Health Sciences, University of Catania, Catania 95125, Italy
- 7 Neuropharmacology and Translational Neurosciences Research Unit, Oasi Research Institute-IRCCS, Troina 94018, Italy
Received: May 5, 2025 Accepted: May 29, 2025 Published: May 31, 2025
https://doi.org/10.18632/aging.206263How to Cite
Copyright: © 2025 Cheishvili et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors recently found that the formula for the EpiAgePublic model shown in the “Development and application of the EpiAgePublic model to investigate biological aging dynamics” section contains a typographical error. Specifically, the coefficient for cg24724428 was incorrectly presented as –30.44, whereas the correct value is +30.44.
The model calculates beta values using the formula:
The authors stated that this correction does not affect the experimental outcome or conclusions of the study. The authors sincerely apologize for any inconvenience caused.